EUVIMEDEUVIMED entdecken
Crossref

Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer

Yifan Yu, Lidan Liu, Ying Cai, Tianshu Wang, Kun Qiu, Xinyao Huang, Yiwen Wang, Mingzhi Shi, Man Ni, Chao Han, Xianglu Ji, Liu Cao und 1 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Yifan Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China. Hauptthemen laut MEDLINE: Purines, Breast Neoplasms, RNA, Small Interfering, Aminopyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors, such as ribociclib (RB), limits breast cancer therapy. Although PEG10 siRNA (siPEG10) can counteract this resistance, achieving targeted, synchronized co-delivery to reshape the immunosuppressive tumor microenvironment (TME) remains a formidable challenge. By loading RB and siPEG10 into PEG-β-CD-modified mesoporous silica nanoparticles (PMSNs) and coating them with breast cancer cell membranes (CM), the nanocomposite RB/siPEG10@PMSNs-CM was synthesized. The nanomaterials were characterized for their size, charge, drug loading, and pH-responsive release. Therapeutic efficacy, immunotherapy-related potentials, and underlying mechanisms were evaluated using in vitro functional assays, an anoikis resistance model, and in vivo breast cancer models. Toxicity was assessed in liver and kidney tissue. The nanodrug RB/siPEG10@PMSNs-CM (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PurinesBreast NeoplasmsRNA, Small InterferingAminopyridinesFemaleHumansAnimalsPolyethylene GlycolsMiceCell Line, TumorXenograft Model Antitumor AssaysMice, NudeTumor MicroenvironmentNanoparticlesCell ProliferationMice, Inbred BALB C

Stichwörter der Autor:innen

CyclodextrinNanocompositePEG10Ribociclib

Substanzen

PurinesribociclibRNA, Small InterferingPolyethylene GlycolsAminopyridines

Autor:innen und Institutionen

  • Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.
  • Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.
  • Teaching Center for Basic Medical Experiment, China Medical University, NO.77, Puhe Road, Shenyang, Liaoning, 110122, China.
  • Medical Oncology Department of Gastrointestinal Tumors, Liaoning Cancer Hospital and Institute, Liaoning Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Hospital of China Medical University, Can…
  • Department of Thoracic Surgery, The First Affiliated Hospital of China Medical University, No. 155 Nangjing Street, Shenyang, Liaoning Province, 110001, China.
  • School of Veterinary Medicine, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, 225009, China.

Förderung

  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Yu, Y., Liu, L., Cai, Y., Wang, T., Qiu, K., Huang, X., Wang, Y., Shi, M., Ni, M., Han, C., Ji, X., Cao, L., & Liu, X. (2026). Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218737

Vancouver

Yu Y, Liu L, Cai Y, Wang T, Qiu K, Huang X, et al. Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218737

BibTeX
@article{Yu2026,
  author = {Yu, Yifan and Liu, Lidan and Cai, Ying and Wang, Tianshu and Qiu, Kun and Huang, Xinyao and Wang, Yiwen and Shi, Mingzhi and Ni, Man and Han, Chao and Ji, Xianglu and Cao, Liu and Liu, Xiangli},
  title = {Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218737}
}
Kostenlos starten →